HIV合并结核患者系统性糖皮质激素治疗的有效性与安全性:随机对照试验的系统综述与Meta分析
该系统综述与Meta分析检索了截至2024年9月19日的多个数据库,纳入7项随机对照试验共1410例HIV阳性结核患者。糖皮质激素使用未显著降低全因死亡率(RR=0.91,95%CI:0.79-1.04,P=0.17),也未显著增加严重不良事件(RR=0.96,95%CI:0.82-1.13,P=0.63)。结论认为需要大规模、延长随访的随机对照试验来探索亚组潜在获益并优化治疗方案。
要点
- 糖皮质激素未显著降低HIV合并结核患者全因死亡率(RR=0.91,95%CI:0.79-1.04,P=0.17)。
- 糖皮质激素未显著增加严重不良事件(RR=0.96,95%CI:0.82-1.13,P=0.63)。
- 作者认为需大规模延长随访的随机对照试验探索亚组获益并优化方案。
核心结论
- 在7项随机对照试验共1410例HIV阳性结核患者中,糖皮质激素治疗既未显著降低全因死亡率,也未显著增加严重不良事件。
- 作者认为需要大规模、延长随访的随机对照试验来探索亚组潜在获益、优化治疗方案并为临床指南提供依据。
研究设计与样本
- 系统综述与Meta分析,检索PubMed、Embase、Web of Science和Cochrane数据库,检索日期为2024年9月19日。
- 纳入7项随机对照试验,共1410例HIV阳性结核患者。
- 主要结局为全因死亡率,次要结局包括严重不良事件,采用随机效应模型计算风险比(RR)及95%置信区间(CI)。
主要发现
- 糖皮质激素使用未显著降低全因死亡率(RR=0.91,95%CI:0.79-1.04,P=0.17)。
- 糖皮质激素使用未显著增加严重不良事件(RR=0.96,95%CI:0.82-1.13,P=0.63)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者指出需要大规模、延长随访的随机对照试验来探索亚组潜在获益、优化治疗方案并为临床指南提供依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The efficacy and safety of corticosteroids in patients with human immunodeficiency virus (HIV) and tuberculosis (TB) remain controversial. METHOD: PubMed, Embase, Web of Science, and the Cochrane Database were searched on 19 September 2024. The primary outcome was all-cause mortality, whereas secondary outcomes included serious adverse events. A random-effects model calculated risk ratios (RR) with 95% confidence intervals (CIs). RESULTS: Seven randomized controlled trials (RCTs) involving 1410 HIV-positive TB patients were included. Corticosteroid use did not significantly reduce all-cause mortality (RR = 0.91, 95% CI: .79-1.04, P = .17) and did not significantly increase serious adverse events (RR = 0.96, 95% CI: .82-1.13, P = .63). CONCLUSIONS: This meta-analysis of 7 RCTs involving 1410 HIV-positive TB patients found that corticosteroid treatment neither significantly reduced all-cause mortality nor increased serious adverse events. Furthermore, large-scale RCTs with extended follow-up are needed to explore potential benefits in subgroups, optimize treatment protocols, and inform clinical guidelines.
引用
- Pu J, Wu S, He JQ, et al. Efficacy and Safety of Systematic Corticosteroids Treatment Among Patients With HIV and Tuberculosis: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Clin Infect Dis. 2025. PMID: 39527080. doi:10.1093/cid/ciae563
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。